ENZO BIOCHEM, INC. Marketable Securities
ENZO BIOCHEM, INC. had Marketable Securities of $29.81 million as of 2021-10-31, per its 10-Q filed 2021-12-15.
Discontinued › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2022-10-14
- 2021-10-31: Marketable Securities $29.81M.
- 2021-07-31: Marketable Securities $29.98M.
- 2020-07-31: Marketable Securities $29.98M.
| Period end | Marketable Securities |
|---|---|
| 2021-10-31 | $29.81M 10-Q · filed 2021-12-15 |
| 2021-07-31 | $29.98M 10-K · filed 2022-10-14 |
| 2020-07-31 | $29.98M 10-K · filed 2021-10-12 |